Marc Beer is the Chief Executive Officer of Renovia Inc. It is a pharmaceutical firm based in Boston. The firm is trying to develop a treatment for pelvic floor disorder. The disease like urinary infections affects a large percentage of women worldwide. Marc Beer founded Renovia Inc. and some of his associates. Marc Beer invested $32 million for use in coming up with new drugs for the treatment. Renovia Inc. is developing equipment and diagnosis that can be used to treat pelvic floor disorder. The firm came up with the first health care product, Leva to be used to diagnose the disease. The product got approved by the FDA a few months after it was released. Marc believes that with the correct diagnosis they can help millions of women.
Several therapeutic firms are coming together to help Renovia Inc. in developing a cure. One of these firms is the Longwood Fund that had initially invested in Renovia. Longwood Fund is an investment firm that only deals with medical institutions. Missouri-based Ascension Ventures and the New York Perspective Advisors lead the series B financing firms. The firms are funding the research on four new drugs for the treatment of pelvic floor disorder and would even like to make an upgrade of the Leva drug. Marc is delighted to be getting support from other therapeutic firms that are concerned with women’s health. The other firms are sharing the same vision as Renovia. Renova’s vision is to cure as many women as they can.
Marc believes that through combining ideas and technological equipment coming up with a cure will not be as difficult as it was initially. Marc is creating a platform that gives individuals a better understanding of pelvic floor disorder; its treatment options and affordable prices for patients that would like to get treatment. Marc Beer is not only the founder and CEO of Renovia Inc. but has also founded several other firms. In 2000 he founded ViaCell, a firm that collects, preserves and studies the umbilical cord stem blood cells. He led the coming to success by ensuring that there were continuous growth and profit margins.
Through Marc Beer’s management, the company has grown tremendously creating employment opportunities. ViaCell became publicized in 2005, and currently, PerkinElmer manages the firm. Marc is among the board of directors of various firms. He helps in making agreements on important decisions and even creates growth strategies for firms. He has worked with Genzyme and is currently working with Global Marketing as the Vice President. His principal role is to announce the launch of new products for the cure of significant diseases. Marc is also among the committee members for pharmaceutical firms that discuss significant health-related problems. Learn more: https://www.crunchbase.com/person/marc-beer